Evidence map›Paper›PMID 42584722›Full record

ArticleNeurosurgical review2026

Evaluation of corneal subbasal nerve plexus as a predictor of radiosurgery outcome in trigeminal neuralgia.

Furkan Almas, Ali Haluk Düzkalir, Dogu Cihan Yildirim, Mehmet Orbay Askeroglu, Ayse Yildiz, Umit Yasar Guleser, Afsun Sahin, Selcuk Peker

Abstract read
PubMed Publisher
In one paragraph

Article in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Furkan AlmasDepartment of Neurosurgery, Gamma Knife Center, Koç University Hospital, Istanbul, Turkey.ORCID http://orcid.org/0009-0003-2931-1654
Ali Haluk DüzkalirDepartment of Neurosurgery, Gamma Knife Center, Koç University Hospital, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-2535-9832
Dogu Cihan YildirimDepartment of Neurosurgery, Gamma Knife Center, Koç University Hospital, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-8323-8932
Mehmet Orbay AskerogluDepartment of Neurosurgery, Gamma Knife Center, Koç University Hospital, Istanbul, Turkey.ORCID http://orcid.org/0000-0001-7126-6373
Ayse YildizDepartment of Ophthalmology, Koç University Hospital, Istanbul, Turkey.ORCID http://orcid.org/0000-0003-1716-5488
Umit Yasar GuleserDepartment of Ophthalmology, Acibadem Maslak Hospital, Istanbul, Turkey.ORCID http://orcid.org/0000-0003-0355-9806
Afsun SahinDepartment of Ophthalmology, Koç University Hospital, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-5083-5618
Selcuk PekerDepartment of Neurosurgery, Gamma Knife Center, Koç University Hospital, Istanbul, Turkey. peker@selcukpeker.com.ORCID http://orcid.org/0000-0003-3057-3355

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gamma Knife radiosurgery (GKRS) is an established treatment for trigeminal neuralgia (TGN); however, no validated biomarkers exist to predict outcomes. In vivo confocal microscopy (IVCM) allows noninvasive quantification of corneal subbasal nerve plexus (SBP) and dendritic cell (DC) density, potentially reflecting trigeminal nerve integrity. This study investigated whether IVCM-derived corneal parameters correlate with and predict pain relief after GKRS in medically refractory TGN. 27 patients with medically refractory idiopathic TGN and 40 healthy controls underwent ophthalmologic examination and IVCM imaging. Pre-treatment parameters included corneal nerve fiber density (CNFD), branch density (CNBD), fiber length (CNFL), total branch density (CTBD), fiber area (CNFA), fiber width (CNFW), fractal dimension (CNFrD), and DC density. GKRS was performed with a single 4-mm collimator shot targeting the retrogasserian portion of the trigeminal nerve (80-90 Gy). Clinical outcomes were assessed using the Barrow Neurological Institute (BNI) Pain Intensity Scale at 12 months. Associations between IVCM parameters and change in BNI score (ΔBNI) were evaluated using correlation and regression analyses, with Benjamini-Hochberg correction for multiple comparisons. A complementary responder-based analysis defined favorable response as BNI I-IIIb at 12 months. Compared with controls, TGN eyes exhibited significantly lower CNFD, CNBD, CNFL, CNFA, and CNFrD (all p < 0.05). Following GKRS, CNFD further decreased (p = 0.034), while DC density increased (p = 0.025). ΔBNI correlated negatively with baseline CNFD (r = -0.526, unadjusted p = 0.003), CNBD (r = -0.500, unadjusted p = 0.006), CNFL (r = -0.436, unadjusted p = 0.018), and CTBD (r = -0.393, unadjusted p = 0.035). After false discovery rate correction, the associations with CNFD, CNBD, and CNFL remained statistically significant. In multivariate analysis, CNFD showed the strongest association with ΔBNI (β = -0.498, p = 0.006; R² = 0.258). Twenty-three patients (85.2%) achieved a favorable response. Baseline ipsilateral CNFD demonstrated moderate but statistically non-significant discrimination for favorable response, with an area under the curve of 0.707 (95% CI, 0.513-0.900; p = 0.195). Lower baseline CNFD was associated with greater pain improvement after GKRS and showed modest discriminatory performance for favorable response. CNFD may represent a candidate noninvasive biomarker of trigeminal nerve dysfunction and radiosurgical response; however, the findings are exploratory and require validation in larger multicenter cohorts.

Indexed as

CorneaRadiosurgeryTrigeminal NerveTrigeminal NeuralgiaAgedFemaleHumansMaleMicroscopy, ConfocalMiddle AgedNerve FibersTreatment OutcomeCorneal nerve fiber densityDendritic cellGamma knife radiosurgeryIn vivo confocal microscopyTrigeminal neuralgia

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.